ClinicalTrials.gov
public full text
Public Domain
Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function
The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation#1057885
- Cigarette smoke and tumor microenvironment copromote aggressiveness of human breast cancer cells#971039
- Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors#887524
- Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca#969406
- Comparison Study of PF530 and Betaferon in Healthy Subjects#830905
Record · ID 852921
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive